TrialClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2013

Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response.

P Sánchez-Rovira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.